Substance use disorders : from etiology to treatment
Author(s)
Bibliographic Information
Substance use disorders : from etiology to treatment
（Handbook of experimental pharmacology, 258）
Springer, c2020
Available at 2 libraries
Note
Includes bibliographical references
Description and Table of Contents
Description
The purpose of this book is to provide a broad scope of substance use disorder research and how these findings can impact treatment outcomes. The research and outcomes described in this book represent important principles related to identifying and understanding factors related to substance use disorders. The first section is dedicated to methodology including population-based surveys, basic neuroanatomy, chemistry, molecular biology, behavioral models and brain imaging. The second section utilizes this methodology in research related to opioids, cocaine, marijuana, alcohol and nicotine. The book is aimed at both professionals (academics, clinicians, practitioners) and students or trainees.
Table of Contents
1. Methods for Population Research on Substance Use and Consequences
Mark Wolfson, Kimberly G. Wagoner, Eunyoung Y. Song, Melinda Pankratz, Sunday Azagba
2. Translational Molecular Approaches in Substance Abuse Research
Sasha L. Fulton and Ian Maze
3. Small Molecule Neuropeptide-S and Melanocortin Receptor Ligands As Potential Treatments for Substance Use Disorders
Bruce Blough and Ojas Namjoshi
4. Emerging Insights into Mu Opioid Pharmacology
Gavril W. Pasternak, Steven R. Childers, and Ying-Xian Pan
5. Behavioral Pharmacology of Drugs Acting at Mu Opioid Receptors
Lisa R. Gerak, David R. Maguire, and Charles P. France
6. The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research
Matthew L. Banks
7. Clinical Trials for Opioid Use Disorder
Esther Blessing, Sanya Virani, and John Rotrosen
8. Modelling Differential Vulnerability to Substance Use Disorder in Rodents: Neurobiological Mechanisms
Bianca Jupp, Jolyon A. Jones, and Jeffrey W. Dalley
9. Activity-Dependent Epigenetic Remodeling in Cocaine Use Disorder
Alberto J. Lopez, Cody A. Siciliano, and Erin S. Calipari
10. Molecular Mechanisms of Amphetamines
Maarten E. A. Reith and Margaret E. Gnegy
11. Clinical Trials for Stimulant Use Disorders: Addressing Heterogeneities That May Undermine Treatment Outcomes
Paul S. Regier, Kyle M. Kampman, and Anna Rose Childress
12. Molecular Mechanism and Cannabinoid Pharmacology
Lesley D. Schurman, Dai Lu, Debra A. Kendall, Allyn C. Howlett, 3 and Aron H. Lichtman
13. Pharmacotherapies for Cannabis Use Disorders: Clinical Challenges and Promising Therapeutic Agents
Suzanne Nielsen, Pamela Sabioni, Linda Gowing, and Bernard Le Foll
14. Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
Christie D. Fowler, Jill R. Turner, and M. Imad Damaj
15. Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade
Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan, and Bernard Le Foll
16. Adolescent Vulnerability to Alcohol Use Disorder: Neurophysiological Mechanisms from Preclinical Studies
Brian A. McCool and Molly M. McGinnis
17. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies
Lorenzo Leggio, Daniel E. Falk, Megan L. Ryan, Joanne Fertig, 3 and Raye Z. Litten
18. Newly Emerging Drugs of Abuse
Kenichi Tamama and Michael J. Lynch
by "Nielsen BookData"